tradingkey.logo
tradingkey.logo
Search

EDAP TMS ADR Reptg 1 Ord Shs

FOCL
Add to Watchlist
3.245USD
-0.165-4.84%
Close 11-13 16:00(ET)
149.12MMarket Cap
0.00P/E TTM

About EDAP TMS ADR Reptg 1 Ord Shs Company

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners

EDAP TMS ADR Reptg 1 Ord Shs Profile

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of EDAP TMS ADR Reptg 1 Ord Shs

Name
Name/Position
Position
Shareholding
Change
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.29M
+3.87%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
658.83K
+3.19%
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
15.10K
+66.23%
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
11.00K
-569.70%
Mr. Herve De Soultrait
Mr. Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Ms. Blandine Confort
Ms. Blandine Confort
Investor Relations Officer, Director - Legal Affairs
Investor Relations Officer, Director - Legal Affairs
--
--
Mr. Kenneth S. Mobeck
Mr. Kenneth S. Mobeck
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Josh Levine
Mr. Josh Levine
Independent Director
Independent Director
--
--
Mr. Frederic Pech
Mr. Frederic Pech
President of EDAP TMS France SAS
President of EDAP TMS France SAS
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.29M
+3.87%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
658.83K
+3.19%
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
15.10K
+66.23%
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
11.00K
-569.70%
Mr. Herve De Soultrait
Mr. Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--

FAQs

Who are the top five shareholders of EDAP TMS ADR Reptg 1 Ord Shs?

The top five shareholders of EDAP TMS ADR Reptg 1 Ord Shs are: Dr. Lance Willsey
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.